Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues.

Suhara Y, Takayama H, Nakane S, Miyashita T, Waku K, Sugiura T.

Chem Pharm Bull (Tokyo). 2000 Jul;48(7):903-7.

PMID:
10923815
2.

The endocannabinoid system as a target for therapeutic drugs.

Piomelli D, Giuffrida A, Calignano A, Rodríguez de Fonseca F.

Trends Pharmacol Sci. 2000 Jun;21(6):218-24. Review.

PMID:
10838609
3.

Miltefosine--the long-awaited therapy for visceral leishmaniasis?

Herwaldt BL.

N Engl J Med. 1999 Dec 9;341(24):1840-2. No abstract available.

PMID:
10588972
4.

Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines.

Konstantinov SM, Berger MR.

Cancer Lett. 1999 Oct 1;144(2):153-60.

PMID:
10529015
5.

Pharmacology of cannabinoid receptor ligands.

Pertwee RG.

Curr Med Chem. 1999 Aug;6(8):635-64. Review.

PMID:
10469884
6.

Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer.

Terwogt JM, Mandjes IA, Sindermann H, Beijnen JH, ten Bokkel Huinink WW.

Br J Cancer. 1999 Mar;79(7-8):1158-61.

7.

Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds.

Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, Ishima Y.

J Biol Chem. 1999 Jan 29;274(5):2794-801.

8.

Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid.

Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M.

Eur J Pharmacol. 1998 Nov 27;362(1):R1-3.

PMID:
9865537
9.

Cardiovascular actions of cannabinoids and their generation during shock.

Wagner JA, Varga K, Kunos G.

J Mol Med (Berl). 1998 Nov-Dec;76(12):824-36. Review.

PMID:
9846953
10.

Endocannabinoids.

Mechoulam R, Fride E, Di Marzo V.

Eur J Pharmacol. 1998 Oct 16;359(1):1-18. Review.

PMID:
9831287
11.

Cytotoxic etherphospholipid analogues.

Berkovic D.

Gen Pharmacol. 1998 Oct;31(4):511-7. Review.

PMID:
9792208
12.

Cannabinoid receptors and immunity.

Klein TW, Newton C, Friedman H.

Immunol Today. 1998 Aug;19(8):373-81. Review. No abstract available.

PMID:
9709506
13.

Cannabinoid receptors and their endogenous agonist, anandamide.

Axelrod J, Felder CC.

Neurochem Res. 1998 May;23(5):575-81. Review.

PMID:
9566594
14.

Glyceryl-ether monooxygenase [EC 1.14.16.5]. A microsomal enzyme of ether lipid metabolism.

Taguchi H, Armarego WL.

Med Res Rev. 1998 Jan;18(1):43-89. Review.

PMID:
9436181
15.

Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor.

Hanus L, Gopher A, Almog S, Mechoulam R.

J Med Chem. 1993 Oct 1;36(20):3032-4. No abstract available.

PMID:
8411021
16.

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent.

Fride E, Mechoulam R.

Eur J Pharmacol. 1993 Feb 9;231(2):313-4.

PMID:
8384116
17.

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.

Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, et al.

Biochem Pharmacol. 1995 Jun 29;50(1):83-90.

PMID:
7605349
18.

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.

Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K.

Biochem Biophys Res Commun. 1995 Oct 4;215(1):89-97.

PMID:
7575630
19.
20.

Supplemental Content

Support Center